Logo-jcvtr

J Cardiovasc Thorac Res. 2020;12(3): 214-221. doi: 10.34172/jcvtr.2020.37
PMID: 33123328        PMCID: PMC7581844

Original Article

Relationship of hypomethylation CpG islands in interleukin-6 gene promoter with IL-6 mRNA levels in patients with coronary atherosclerosis

Monireh Mohammadpanah 1 ORCID, Mohammad Mehdi Heidari 1 * ORCID, Mehri Khatami 1 ORCID, Mehdi Hadadzadeh 2 ORCID

Cited by CrossRef: 4

1- Yang J, Wang J, Li H, Gao S, Fan Y, Wang K. IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Front Oncol. 2022;12 [Crossref]
2- Zhang L, Xia C, Yang Y, Sun F, Zhang Y, Wang H, Liu R, Yuan M. DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy. Cell Commun Signal. 2023;21(1) [Crossref]
3- Pérez-Hernández N, Posadas-Sánchez R, Vargas-Alarcón G, Pérez-Méndez Ó, Luna-Luna M, Rodríguez-Pérez J. DNA Methylation of the IL-17A Gene Promoter Is Associated with Subclinical Atherosclerosis and Coronary Artery Disease: The Genetics of Atherosclerotic Disease Mexican Study. CIMB. 2023;45(12):9768 [Crossref]
4- Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-Mazur J, Mak M, Rek-Owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-Heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Greater methylation of the IL-6 promoter region is associated with decreased integrity of the corpus callosum in schizophrenia. Journal of Psychiatric Research. 2024;175:108 [Crossref]
5- Chen J, Liu Z, Ma L, Gao S, Fu H, Wang C, Lu A, Wang B, Gu X. Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics. Front Genet. 2021;12 [Crossref]
6- Mingalimova A, Drapkina O, Sagirov M, Mazanov M, Bikbova M, Argir I. Inflammatory continuum in the pathogenesis of atrial fibrillation after coronary bypass surgery. Cardiovasc Ther Prev. 2022;21(3):3094 [Crossref]
7- Shi W, Fuad A, Li Y, Wang Y, Huang J, Du R, Wang G, Wang Y, Yin T. Biodegradable polymeric nanoparticles increase risk of cardiovascular diseases by inducing endothelium dysfunction and inflammation. J Nanobiotechnol. 2023;21(1) [Crossref]